-

United States Electronic Health Record (EHR) Market Insights Report 2023-2028: Market Dynamics, Competitive Landscape, Strategic Recommendations - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "US Electronic Health Record (EHR) Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering.

US Electronic Health Record (EHR) Market is projected to reach a value of $12.88 billion from $9.12 billion, growing at a CAGR of 5.9% during 2022-2028

The utilization of Electronic Health Records (EHR) in the United States has seen remarkable growth, with adoption rates soaring post-COVID-19. As of 2021, an impressive four out of five physicians, and over 90% of non-federal acute care facilities, have embraced EHR systems. This trend continues to escalate, driven by ongoing healthcare reforms.

EHR systems are revolutionizing healthcare by significantly reducing errors, automating workflows, enhancing patient management, and providing easy access to accurate information. Physicians are benefiting from streamlined workflows, allowing them to dedicate more time to patient care and expedite reimbursement filing processes.

The success of value-based healthcare relies on the seamless integration of doctors, patients, caregivers, IT professionals, and EHR vendors. Value-based healthcare emphasizes cost-effective, high-quality treatments. As reimbursement models for various treatments under value-based solutions undergo constant change, EHR systems play a pivotal role in ensuring efficient healthcare delivery.

Cloud-based EHR systems are the preferred choice in the market due to their user-friendliness and minimal maintenance requirements. This segment is poised for rapid growth, with an anticipated absolute growth rate exceeding 45%. EHR systems provide crucial clinical functions such as health information management, results tracking, order processing, and decision support. Their primary objective is to efficiently manage the information needed by healthcare professionals to deliver effective care.

The clinical research sector is experiencing substantial growth, with the introduction of remote clinical trials and increased adoption of digital tools. EHR systems play a vital role in handling large volumes of data and enabling real-time research tracking. Healthcare administrative databases serve as valuable resources for research purposes, though they come with limitations such as data duplication. EHR software effectively addresses duplication issues, further enhancing their utility in research.

The healthcare landscape is witnessing an upsurge in healthcare facilities, a continuous rise in the patient population, and rapid digitalization, propelling the market toward innovative advancements.

MARKET STRUCTURE

  • Market Dynamics
  • Competitive Landscape
  • Key Vendors
  • Other Prominent Vendors
  • Strategic Recommendations
  • Quantitative Summary
  • Abbreviations

VENDORS LIST

Key Vendors

  • Epic
  • Oracle
  • Meditech

Other Prominent Vendors

  • Eclinicalworks
  • Amkai Solutions
  • Amrita Medical Solutions
  • Angel's Avenue
  • Askesis Development Group
  • Cantata
  • Cgi
  • Credible
  • Dss
  • Empowersystems
  • Evident
  • Feisystems
  • Harris Healthcare
  • Healthcare Software
  • Icanotes
  • Indian Health Services
  • Infomedika
  • Intersystems
  • Marshfield Clinic's
  • Medconnect
  • Medez
  • Medspehre Systems Corporation
  • Meta Healthcare It Solutions
  • Mindlinc
  • Morris Systems
  • Netsmart Technologies
  • Nextgen
  • Ntt Data
  • Optimus Emr
  • Prognosis Innovation Healthcare
  • Psytech Solutions
  • Qualifacts Systems
  • Sigma Care
  • Sigmund Software
  • Source Medical Solutions
  • Technomad
  • Tenzing Medical
  • World Vista
  • Athenahealth
  • Allscripts
  • Medhost

SEGMENTATION & FORECAST

Deployment

  • Cloud-Based
  • On-Premise

End-User

  • Hospitals
  • Diagnostic Imaging Centers
  • Standalone Urgent/Emergency Centres
  • Others

Application

  • Clinical
  • Administrative
  • Reporting Healthcare System
  • Healthcare Financing
  • Clinical Research

For more information about this report visit https://www.researchandmarkets.com/r/qwdv93

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

The Role of the Person Responsible for Regulatory Compliance (PRRC) Under the MDR (Medical Device Regulation) and IVDR (In-Vitro Diagnostic Regulation) Training Course (ONLINE EVENT: May 22, 2025) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The Role of the Person Responsible for Regulatory Compliance (PRRC) Under the MDR (Medical Device Regulation) and IVDR (In-Vitro Diagnostic Regulation) Training Course" training has been added to ResearchAndMarkets.com's offering. Attend this one-day course to gain a comprehensive understanding of the critical role of the Person Responsible for Regulatory Compliance (PRRC) introduced by the Medical Device Regulation 2017/745 and the In-Vitro Diagnostic Device Regul...

Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Training Course: Navigate CIS Pharmaceutical Markets with Expert Guidance on Evolving Regulations (ONLINE EVENT: June 19-20, 2025) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Training Course" training has been added to ResearchAndMarkets.com's offering. This interactive course will guide you through national procedures as well as explore the implications of and updates on the Eurasian Union regulation. The focus of the programme is to offer practical advice in developing your regulatory strategy for product approval in these countries and you will get the full benefit of...

U.S. Orphan Designated Drugs Market Research Report 2025: $190 Billion Opportunities, Drugs Sales, Price, Dosage & Clinical Trials Insights to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. Report Offering & Highlights: U.S. Orphan Designated Drugs Market Opportunity: > U.S.$ 190 Billion by 2030 Insight on FDA Designated Orphan Drugs in Clinical Trials: > 850 Orphan Drugs Clinical Trials Insight by Company, Indication, Phase & Priority Status Insight on FDA Designated...
Back to Newsroom